Literature DB >> 35417979

Spinal anesthesia for open gastrostomy in an infant after stage I Norwood for hypoplastic left heart.

Michael A Acquaviva1, Doris M Hardacker1, Senthil Packiasabapathy1, Robert C Burns2.   

Abstract

Infants with hypoplastic left heart are at increased risk of adverse events including mortality when they undergo procedures with general anesthesia in the inter-stage period after stage I Norwood. This is primarily caused by an imbalance between pulmonary and systemic blood flows augmented by decreased function of the single ventricle. These factors can be aggravated by general anesthesia, hence the increased risk. Many of these infants experience feeding dysfunction and require a gastrostomy to optimize nutrition. We report a case of open gastrostomy in an infant with Norwood physiology under spinal anesthesia with an excellent outcome.

Entities:  

Keywords:  Gastrostomy; Norwood; hypoplastic left heart syndrome; infant spinal; spinal anesthesia; sub-arachnoid block

Mesh:

Year:  2022        PMID: 35417979      PMCID: PMC9244275          DOI: 10.4103/aca.aca_262_20

Source DB:  PubMed          Journal:  Ann Card Anaesth        ISSN: 0971-9784


  10 in total

1.  Perioperative management of infants undergoing fundoplication and gastrostomy after stage I palliation of hypoplastic left heart syndrome.

Authors:  Scott Watkins; Stephen E Morrow; Brent S McNew; Brian S Donahue
Journal:  Pediatr Cardiol       Date:  2012-06       Impact factor: 1.655

2.  Patients with single ventricle physiology undergoing noncardiac surgery are at high risk for adverse events.

Authors:  Morgan L Brown; James A DiNardo; Kirsten C Odegard
Journal:  Paediatr Anaesth       Date:  2015-05-13       Impact factor: 2.556

Review 3.  Anesthesia in Pediatric Patients With Congenital Heart Disease Undergoing Noncardiac Surgery: Defining the Risk.

Authors:  Morgan L Brown; James A DiNardo; Viviane G Nasr
Journal:  J Cardiothorac Vasc Anesth       Date:  2019-06-15       Impact factor: 2.628

4.  Spinal anesthesia compared with general anesthesia for neonates with hypertrophic pyloric stenosis. A retrospective study.

Authors:  María Pilar Sánchez-Conde; Agustín Díaz-Alvarez; Miguel Ángel Palomero Rodríguez; María Isabel Garrido Gallego; Guillermo Martín Rollan; Jesús de Vicente Sánchez; Yolanda Laporta Báez; Luis Mario Vaquero Roncero; José María Rodríguez López
Journal:  Paediatr Anaesth       Date:  2019-08-09       Impact factor: 2.556

5.  Noncardiac surgery in children with hypoplastic left heart syndrome.

Authors:  Adalberto Torres; John DiLiberti; Richard H Pearl; Julie Wohrley; Gary W Raff; G Kris Bysani; Linda M Bond; Dale M Geiss
Journal:  J Pediatr Surg       Date:  2002-10       Impact factor: 2.545

Review 6.  Feeding complications in hypoplastic left heart syndrome after the Norwood procedure: a systematic review of the literature.

Authors:  Jessica R Golbus; Brandon M Wojcik; John R Charpie; Jennifer C Hirsch
Journal:  Pediatr Cardiol       Date:  2011-02-20       Impact factor: 1.655

7.  Spinal anaesthesia in a child with hypoplastic left heart syndrome.

Authors:  S Sacrista; D Kern; O Fourcade; P Izard; P Galinier; K Samii; B Cathala
Journal:  Paediatr Anaesth       Date:  2003-03       Impact factor: 2.556

8.  Gastrostomy tube placement among infants with hypoplastic left heart syndrome undergoing stage 1 palliation.

Authors:  Parthak Prodhan; Xinyu Tang; Jeffrey Gossett; Brandon Beam; Janet Simsic; Nancy Ghanayem; Nahed O ElHassan
Journal:  Congenit Heart Dis       Date:  2018-05-13       Impact factor: 2.007

9.  Prognostic Value of Serial Echocardiography in Hypoplastic Left Heart Syndrome.

Authors:  Jae Sung Son; Adam James; Chun-Po Steve Fan; Luc Mertens; Brian W McCrindle; Cedric Manlhiot; Mark K Friedberg
Journal:  Circ Cardiovasc Imaging       Date:  2018-07       Impact factor: 7.792

10.  Prognostic Value of Serial Echocardiography in Hypoplastic Left Heart Syndrome: Smaller Hearts, Better Results.

Authors:  Laura Mercer-Rosa; David J Goldberg
Journal:  Circ Cardiovasc Imaging       Date:  2018-07       Impact factor: 7.792

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.